Global Lung Biopsy Systems Market Growth (Status and Outlook) 2026-2032
The global Lung Biopsy Systems market size is predicted to grow from US$ 5596 million in 2025 to US$ 10934 million in 2032; it is expected to grow at a CAGR of 14.2% from 2026 to 2032.
Lung Biopsy Systems refer to a set of diagnostic equipment used to safely obtain lung tissue or cytology specimens when evaluating suspicious pulmonary lesions or diffuse lung diseases, typically under endoscopic visualization and or imaging based navigation guidance. A typical system combines a bronchoscope or percutaneous sampling instrument, navigation and localization software or a robotic platform, sampling consumables, and supporting energy or processing units. The scope of this research includes transbronchial biopsy forceps and other miniature sampling tools used in conventional or interventional bronchoscopy, cryobiopsy workstations and cryoprobes used for transbronchial cryobiopsy, lung navigation systems that integrate modalities such as electromagnetic navigation and fluoroscopic guidance, and robotic assisted bronchoscopy platforms designed to reach peripheral lung nodules and support tool in lesion confirmation. It may also be extended to include core needle biopsy instruments used for sampling soft tissues such as the lung. This research excludes the surgical service of open or thoracoscopic lung biopsy, laboratory pathology testing and staining consumables, and standalone imaging equipment such as CT or ultrasound systems. Core use cases include lesion characterization after lung cancer screening, histologic confirmation of peripheral small nodules or ground glass nodules, sampling for mediastinal and hilar staging, and tissue acquisition for interstitial lung disease. The value of these systems lies in improving reach and sample yield, reducing repeat punctures and complication risks, lowering cross infection risk and turnaround costs through single use bronchoscopes and consumable kits, and enabling repeatable standardized workflows and recurring consumable revenues supported by software and robotic assistance. Key customers include tertiary hospitals in pulmonology and thoracic surgery, cancer centers and interventional radiology departments, and specialty clinics that run pulmonary nodule programs and day case procedures. Commercial delivery is commonly structured as capital equipment plus single use consumables or service contracts, and can also incorporate subscription based software modules for navigation planning and data management.
Under the expansion of pulmonary nodule screening and rising demand for early diagnosis, Lung Biopsy Systems are evolving from single sampling tools into end to end solutions centered on reach and confirmation. Robotic assisted bronchoscopy platforms combine stable steerability and distal control with navigation modalities such as shape sensing or imaging fusion, enabling more reliable access to peripheral airways and small nodules that are difficult to reach with conventional bronchoscopes. They embed sampling and tool in lesion confirmation into one workflow, improving diagnostic yield and shortening the path from imaging detection to histologic confirmation. In parallel, electromagnetic and fluoroscopic navigation systems provide a lower barrier pathway in cost and deployment, enhancing localization and route planning without replacing existing bronchoscopy infrastructure, allowing more hospitals to adopt minimally invasive sampling for peripheral lesions. As clinicians increasingly prioritize procedural consistency and learning curve, manufacturers are pushing standardized software workflows, training programs, and matched consumable sets, shifting the field from expert experience driven practice toward device and data driven practice. A key clinical pain point is that smaller and more peripheral lesions are harder to stabilize due to scope bending and recoil, leading to failed sampling or repeated attempts. Shape sensing style navigation reduces reliance on fluoroscopy by providing real time catheter shape and location feedback and can link with CT based airway reconstruction to maintain route consistency in complex branching airways. For hospital operators, the value extends beyond per case yield to include room throughput, reduced anesthesia and length of stay, and measurable quality metrics that support multi center collaboration and research.
Sample quality and safety remain the core competitive dimensions, and consumable innovation directly determines achievable tissue volume and complication control. Conventional biopsy forceps are mature and broadly applicable in bronchoscopy, supporting rapid sampling for central airway disease and selected peripheral targets. To meet the need for larger tissue pieces in interstitial lung disease and peripheral nodules, transbronchial cryobiopsy leverages cryoadhesion to preserve tissue architecture, creating a high value consumable chain built around cryosurgical workstations and single use or reusable cryoprobes. For the percutaneous route, core needle biopsy instruments can provide standardized cylindrical tissue specimens in soft tissues such as the lung, enabling fast confirmation under imaging guidance, while requiring robust pathway planning and complication management. Single use bronchoscopes and compatible sampling instruments are becoming an important complement, reducing cross infection risk and enabling more stable equipment availability and predictable costs in high throughput units. On the consumables side, manufacturers are improving jaw geometry, opening angle, sheath coating straightness, and rotatable handle structures to increase sampling efficiency and reduce mucosal trauma. Some products use color coding and specification systems to differentiate anatomical applications and working channel compatibility, supporting inventory management and nursing setup. Cryobiopsy emphasizes repeatable freeze timing and probe diameter selection, and protective oversheaths can protect scope channels during extraction and reduce thermal damage risk. For percutaneous biopsy, combinations of automatic or semi automatic firing mechanisms with coaxial needle systems help maintain the pathway while enabling multiple passes, increasing diagnostic information per procedure. With accumulating guidelines and evidence, hospitals are more likely to adopt a stratified approach by lesion type, driving coexistence of multiple techniques rather than one technology fully replacing another.
Commercially, Lung Biopsy Systems typically grow through a hybrid model of capital platforms plus recurring consumables. Navigation systems and robotic platforms drive upfront capital purchases, while high frequency consumables such as biopsy forceps, needles, and cryoprobes sustain recurring revenue and incentivize ecosystem optimization. Future growth is expected from three areas, deeper penetration of AI and software in pre procedure planning, intra procedure correction, and reporting and data management, higher sampling volumes driven by the expanding screened population and rising peripheral small nodule detection, and procurement mix shifts driven by the growing adoption of single use endoscopes and consumable kits. From a policy and compliance perspective, tighter requirements on quality systems and infection control will further encourage the use of single use devices and traceable consumables. In manufacturing geography, the US and Europe retain advantages in robotic systems and navigation algorithm platforms, while China, Japan, and Korea are strengthening supply capability in single use endoscopy and endoscopic consumables. In sales geography, North America and Europe are likely to continue leading high end platform installations due to mature screening and interventional pulmonology pathways, while Asia Pacific is positioned as a key incremental market supported by hospital capacity expansion and domestic substitution. In tendering and reimbursement environments, more institutions are incorporating Lung Biopsy Systems into early detection and treatment pathways, building closed loops from screening imaging to follow up and tissue confirmation. Manufacturers reduce post installation friction through interoperability with bronchoscopy towers, fluoroscopy and ultrasound equipment, and through training and service offerings. On the supply chain side, capabilities in key components such as high precision sensors and single use insertion tubes will shape cost curves and may improve accessibility in lower tier markets as scale increases. Competition may evolve along two parallel routes, a high end integrated route centered on robotics and navigation platforms, and a high throughput route centered on single use endoscopy plus standardized consumable bundles, with both developing in parallel across regions and hospital tiers.
LPI (LP Information)' newest research report, the ?Lung Biopsy Systems Industry Forecast? looks at past sales and reviews total world Lung Biopsy Systems sales in 2025, providing a comprehensive analysis by region and market sector of projected Lung Biopsy Systems sales for 2026 through 2032. With Lung Biopsy Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lung Biopsy Systems industry.
This Insight Report provides a comprehensive analysis of the global Lung Biopsy Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Lung Biopsy Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Lung Biopsy Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lung Biopsy Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lung Biopsy Systems.
This report presents a comprehensive overview, market shares, and growth opportunities of Lung Biopsy Systems market by product type, application, key players and key regions and countries.
Segmentation by Type:
Lung Biopsy Systems refer to a set of diagnostic equipment used to safely obtain lung tissue or cytology specimens when evaluating suspicious pulmonary lesions or diffuse lung diseases, typically under endoscopic visualization and or imaging based navigation guidance. A typical system combines a bronchoscope or percutaneous sampling instrument, navigation and localization software or a robotic platform, sampling consumables, and supporting energy or processing units. The scope of this research includes transbronchial biopsy forceps and other miniature sampling tools used in conventional or interventional bronchoscopy, cryobiopsy workstations and cryoprobes used for transbronchial cryobiopsy, lung navigation systems that integrate modalities such as electromagnetic navigation and fluoroscopic guidance, and robotic assisted bronchoscopy platforms designed to reach peripheral lung nodules and support tool in lesion confirmation. It may also be extended to include core needle biopsy instruments used for sampling soft tissues such as the lung. This research excludes the surgical service of open or thoracoscopic lung biopsy, laboratory pathology testing and staining consumables, and standalone imaging equipment such as CT or ultrasound systems. Core use cases include lesion characterization after lung cancer screening, histologic confirmation of peripheral small nodules or ground glass nodules, sampling for mediastinal and hilar staging, and tissue acquisition for interstitial lung disease. The value of these systems lies in improving reach and sample yield, reducing repeat punctures and complication risks, lowering cross infection risk and turnaround costs through single use bronchoscopes and consumable kits, and enabling repeatable standardized workflows and recurring consumable revenues supported by software and robotic assistance. Key customers include tertiary hospitals in pulmonology and thoracic surgery, cancer centers and interventional radiology departments, and specialty clinics that run pulmonary nodule programs and day case procedures. Commercial delivery is commonly structured as capital equipment plus single use consumables or service contracts, and can also incorporate subscription based software modules for navigation planning and data management.
Under the expansion of pulmonary nodule screening and rising demand for early diagnosis, Lung Biopsy Systems are evolving from single sampling tools into end to end solutions centered on reach and confirmation. Robotic assisted bronchoscopy platforms combine stable steerability and distal control with navigation modalities such as shape sensing or imaging fusion, enabling more reliable access to peripheral airways and small nodules that are difficult to reach with conventional bronchoscopes. They embed sampling and tool in lesion confirmation into one workflow, improving diagnostic yield and shortening the path from imaging detection to histologic confirmation. In parallel, electromagnetic and fluoroscopic navigation systems provide a lower barrier pathway in cost and deployment, enhancing localization and route planning without replacing existing bronchoscopy infrastructure, allowing more hospitals to adopt minimally invasive sampling for peripheral lesions. As clinicians increasingly prioritize procedural consistency and learning curve, manufacturers are pushing standardized software workflows, training programs, and matched consumable sets, shifting the field from expert experience driven practice toward device and data driven practice. A key clinical pain point is that smaller and more peripheral lesions are harder to stabilize due to scope bending and recoil, leading to failed sampling or repeated attempts. Shape sensing style navigation reduces reliance on fluoroscopy by providing real time catheter shape and location feedback and can link with CT based airway reconstruction to maintain route consistency in complex branching airways. For hospital operators, the value extends beyond per case yield to include room throughput, reduced anesthesia and length of stay, and measurable quality metrics that support multi center collaboration and research.
Sample quality and safety remain the core competitive dimensions, and consumable innovation directly determines achievable tissue volume and complication control. Conventional biopsy forceps are mature and broadly applicable in bronchoscopy, supporting rapid sampling for central airway disease and selected peripheral targets. To meet the need for larger tissue pieces in interstitial lung disease and peripheral nodules, transbronchial cryobiopsy leverages cryoadhesion to preserve tissue architecture, creating a high value consumable chain built around cryosurgical workstations and single use or reusable cryoprobes. For the percutaneous route, core needle biopsy instruments can provide standardized cylindrical tissue specimens in soft tissues such as the lung, enabling fast confirmation under imaging guidance, while requiring robust pathway planning and complication management. Single use bronchoscopes and compatible sampling instruments are becoming an important complement, reducing cross infection risk and enabling more stable equipment availability and predictable costs in high throughput units. On the consumables side, manufacturers are improving jaw geometry, opening angle, sheath coating straightness, and rotatable handle structures to increase sampling efficiency and reduce mucosal trauma. Some products use color coding and specification systems to differentiate anatomical applications and working channel compatibility, supporting inventory management and nursing setup. Cryobiopsy emphasizes repeatable freeze timing and probe diameter selection, and protective oversheaths can protect scope channels during extraction and reduce thermal damage risk. For percutaneous biopsy, combinations of automatic or semi automatic firing mechanisms with coaxial needle systems help maintain the pathway while enabling multiple passes, increasing diagnostic information per procedure. With accumulating guidelines and evidence, hospitals are more likely to adopt a stratified approach by lesion type, driving coexistence of multiple techniques rather than one technology fully replacing another.
Commercially, Lung Biopsy Systems typically grow through a hybrid model of capital platforms plus recurring consumables. Navigation systems and robotic platforms drive upfront capital purchases, while high frequency consumables such as biopsy forceps, needles, and cryoprobes sustain recurring revenue and incentivize ecosystem optimization. Future growth is expected from three areas, deeper penetration of AI and software in pre procedure planning, intra procedure correction, and reporting and data management, higher sampling volumes driven by the expanding screened population and rising peripheral small nodule detection, and procurement mix shifts driven by the growing adoption of single use endoscopes and consumable kits. From a policy and compliance perspective, tighter requirements on quality systems and infection control will further encourage the use of single use devices and traceable consumables. In manufacturing geography, the US and Europe retain advantages in robotic systems and navigation algorithm platforms, while China, Japan, and Korea are strengthening supply capability in single use endoscopy and endoscopic consumables. In sales geography, North America and Europe are likely to continue leading high end platform installations due to mature screening and interventional pulmonology pathways, while Asia Pacific is positioned as a key incremental market supported by hospital capacity expansion and domestic substitution. In tendering and reimbursement environments, more institutions are incorporating Lung Biopsy Systems into early detection and treatment pathways, building closed loops from screening imaging to follow up and tissue confirmation. Manufacturers reduce post installation friction through interoperability with bronchoscopy towers, fluoroscopy and ultrasound equipment, and through training and service offerings. On the supply chain side, capabilities in key components such as high precision sensors and single use insertion tubes will shape cost curves and may improve accessibility in lower tier markets as scale increases. Competition may evolve along two parallel routes, a high end integrated route centered on robotics and navigation platforms, and a high throughput route centered on single use endoscopy plus standardized consumable bundles, with both developing in parallel across regions and hospital tiers.
LPI (LP Information)' newest research report, the ?Lung Biopsy Systems Industry Forecast? looks at past sales and reviews total world Lung Biopsy Systems sales in 2025, providing a comprehensive analysis by region and market sector of projected Lung Biopsy Systems sales for 2026 through 2032. With Lung Biopsy Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lung Biopsy Systems industry.
This Insight Report provides a comprehensive analysis of the global Lung Biopsy Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Lung Biopsy Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Lung Biopsy Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lung Biopsy Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lung Biopsy Systems.
This report presents a comprehensive overview, market shares, and growth opportunities of Lung Biopsy Systems market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Needle Biopsy
- Thoracoscopic Biopsy
- Transbronchial Biopsy
- Bronchoscopic
- Percutaneous
- No Navigation
- Electromagnetic Navigation
- Robotic Navigation
- Shape Sensing
- Hospitals
- Cancer Research Centers
- Specialty Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Intuitive Surgical, Inc.
- Johnson & Johnson MedTech (Ethicon)
- Medtronic plc
- Olympus Corporation
- ERBE Elektromedizin GmbH
- Ambu A/S
- Boston Scientific Corporation
- Cook Medical LLC
- KARL STORZ SE & Co. KG
- Technowood Co., Ltd.
- Sumitomo Bakelite Co., Ltd.
- HOYA Corporation (PENTAX Medical)
- FINEMEDIX CO., LTD.
- Upex-Med Corp.
- Medcare Medical (Medcare Medical Co., Ltd.)
- Argon Medical Devices, Inc.
- Becton, Dickinson and Company (BD)
- Hunan Vathin Medical Instrument Co., Ltd.
- Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
- SonoScape Medical Corp.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Jiangsu Vedkang Medical Science and Technology Co., Ltd.
- Zhuji Peng Tian Medical Instrument Co.,Ltd
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lung Biopsy Systems Market Size (2021-2032)
2.1.2 Lung Biopsy Systems Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Lung Biopsy Systems by Country/Region (2021, 2025 & 2032)
2.2 Lung Biopsy Systems Segment by Type
2.2.1 Needle Biopsy
2.2.2 Thoracoscopic Biopsy
2.2.3 Transbronchial Biopsy
2.2.4 Lung Biopsy Systems Market Size by Type
2.2.4.1 Lung Biopsy Systems Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Lung Biopsy Systems Market Size Market Share by Type (2021-2026)
2.3 Lung Biopsy Systems Segment by Access Route
2.3.1 Bronchoscopic
2.3.2 Percutaneous
2.3.3 Lung Biopsy Systems Market Size by Access Route
2.3.3.1 Lung Biopsy Systems Market Size CAGR by Access Route (2021 VS 2025 VS 2032)
2.3.3.2 Global Lung Biopsy Systems Market Size Market Share by Access Route (2021-2026)
2.4 Lung Biopsy Systems Segment by Navigation Modality
2.4.1 No Navigation
2.4.2 Electromagnetic Navigation
2.4.3 Robotic Navigation
2.4.4 Shape Sensing
2.4.5 Lung Biopsy Systems Market Size by Navigation Modality
2.4.5.1 Lung Biopsy Systems Market Size CAGR by Navigation Modality (2021 VS 2025 VS 2032)
2.4.5.2 Global Lung Biopsy Systems Market Size Market Share by Navigation Modality (2021-2026)
2.5 Lung Biopsy Systems Segment by Application
2.5.1 Hospitals
2.5.2 Cancer Research Centers
2.5.3 Specialty Clinics
2.5.4 Others
2.5.5 Lung Biopsy Systems Market Size by Application
2.5.5.1 Lung Biopsy Systems Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Lung Biopsy Systems Market Size Market Share by Application (2021-2026)
3 LUNG BIOPSY SYSTEMS MARKET SIZE BY PLAYER
3.1 Lung Biopsy Systems Market Size Market Share by Player
3.1.1 Global Lung Biopsy Systems Revenue by Player (2021-2026)
3.1.2 Global Lung Biopsy Systems Revenue Market Share by Player (2021-2026)
3.2 Global Lung Biopsy Systems Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LUNG BIOPSY SYSTEMS BY REGION
4.1 Lung Biopsy Systems Market Size by Region (2021-2026)
4.2 Global Lung Biopsy Systems Annual Revenue by Country/Region (2021-2026)
4.3 Americas Lung Biopsy Systems Market Size Growth (2021-2026)
4.4 APAC Lung Biopsy Systems Market Size Growth (2021-2026)
4.5 Europe Lung Biopsy Systems Market Size Growth (2021-2026)
4.6 Middle East & Africa Lung Biopsy Systems Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Lung Biopsy Systems Market Size by Country (2021-2026)
5.2 Americas Lung Biopsy Systems Market Size by Type (2021-2026)
5.3 Americas Lung Biopsy Systems Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lung Biopsy Systems Market Size by Region (2021-2026)
6.2 APAC Lung Biopsy Systems Market Size by Type (2021-2026)
6.3 APAC Lung Biopsy Systems Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Lung Biopsy Systems Market Size by Country (2021-2026)
7.2 Europe Lung Biopsy Systems Market Size by Type (2021-2026)
7.3 Europe Lung Biopsy Systems Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lung Biopsy Systems by Region (2021-2026)
8.2 Middle East & Africa Lung Biopsy Systems Market Size by Type (2021-2026)
8.3 Middle East & Africa Lung Biopsy Systems Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LUNG BIOPSY SYSTEMS MARKET FORECAST
10.1 Global Lung Biopsy Systems Forecast by Region (2027-2032)
10.1.1 Global Lung Biopsy Systems Forecast by Region (2027-2032)
10.1.2 Americas Lung Biopsy Systems Forecast
10.1.3 APAC Lung Biopsy Systems Forecast
10.1.4 Europe Lung Biopsy Systems Forecast
10.1.5 Middle East & Africa Lung Biopsy Systems Forecast
10.2 Americas Lung Biopsy Systems Forecast by Country (2027-2032)
10.2.1 United States Market Lung Biopsy Systems Forecast
10.2.2 Canada Market Lung Biopsy Systems Forecast
10.2.3 Mexico Market Lung Biopsy Systems Forecast
10.2.4 Brazil Market Lung Biopsy Systems Forecast
10.3 APAC Lung Biopsy Systems Forecast by Region (2027-2032)
10.3.1 China Lung Biopsy Systems Market Forecast
10.3.2 Japan Market Lung Biopsy Systems Forecast
10.3.3 Korea Market Lung Biopsy Systems Forecast
10.3.4 Southeast Asia Market Lung Biopsy Systems Forecast
10.3.5 India Market Lung Biopsy Systems Forecast
10.3.6 Australia Market Lung Biopsy Systems Forecast
10.4 Europe Lung Biopsy Systems Forecast by Country (2027-2032)
10.4.1 Germany Market Lung Biopsy Systems Forecast
10.4.2 France Market Lung Biopsy Systems Forecast
10.4.3 UK Market Lung Biopsy Systems Forecast
10.4.4 Italy Market Lung Biopsy Systems Forecast
10.4.5 Russia Market Lung Biopsy Systems Forecast
10.5 Middle East & Africa Lung Biopsy Systems Forecast by Region (2027-2032)
10.5.1 Egypt Market Lung Biopsy Systems Forecast
10.5.2 South Africa Market Lung Biopsy Systems Forecast
10.5.3 Israel Market Lung Biopsy Systems Forecast
10.5.4 Turkey Market Lung Biopsy Systems Forecast
10.6 Global Lung Biopsy Systems Forecast by Type (2027-2032)
10.7 Global Lung Biopsy Systems Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Lung Biopsy Systems Forecast
11 KEY PLAYERS ANALYSIS
11.1 Intuitive Surgical, Inc.
11.1.1 Intuitive Surgical, Inc. Company Information
11.1.2 Intuitive Surgical, Inc. Lung Biopsy Systems Product Offered
11.1.3 Intuitive Surgical, Inc. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Intuitive Surgical, Inc. Main Business Overview
11.1.5 Intuitive Surgical, Inc. Latest Developments
11.2 Johnson & Johnson MedTech (Ethicon)
11.2.1 Johnson & Johnson MedTech (Ethicon) Company Information
11.2.2 Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Product Offered
11.2.3 Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Johnson & Johnson MedTech (Ethicon) Main Business Overview
11.2.5 Johnson & Johnson MedTech (Ethicon) Latest Developments
11.3 Medtronic plc
11.3.1 Medtronic plc Company Information
11.3.2 Medtronic plc Lung Biopsy Systems Product Offered
11.3.3 Medtronic plc Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Medtronic plc Main Business Overview
11.3.5 Medtronic plc Latest Developments
11.4 Olympus Corporation
11.4.1 Olympus Corporation Company Information
11.4.2 Olympus Corporation Lung Biopsy Systems Product Offered
11.4.3 Olympus Corporation Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Olympus Corporation Main Business Overview
11.4.5 Olympus Corporation Latest Developments
11.5 ERBE Elektromedizin GmbH
11.5.1 ERBE Elektromedizin GmbH Company Information
11.5.2 ERBE Elektromedizin GmbH Lung Biopsy Systems Product Offered
11.5.3 ERBE Elektromedizin GmbH Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 ERBE Elektromedizin GmbH Main Business Overview
11.5.5 ERBE Elektromedizin GmbH Latest Developments
11.6 Ambu A/S
11.6.1 Ambu A/S Company Information
11.6.2 Ambu A/S Lung Biopsy Systems Product Offered
11.6.3 Ambu A/S Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Ambu A/S Main Business Overview
11.6.5 Ambu A/S Latest Developments
11.7 Boston Scientific Corporation
11.7.1 Boston Scientific Corporation Company Information
11.7.2 Boston Scientific Corporation Lung Biopsy Systems Product Offered
11.7.3 Boston Scientific Corporation Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Boston Scientific Corporation Main Business Overview
11.7.5 Boston Scientific Corporation Latest Developments
11.8 Cook Medical LLC
11.8.1 Cook Medical LLC Company Information
11.8.2 Cook Medical LLC Lung Biopsy Systems Product Offered
11.8.3 Cook Medical LLC Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Cook Medical LLC Main Business Overview
11.8.5 Cook Medical LLC Latest Developments
11.9 KARL STORZ SE & Co. KG
11.9.1 KARL STORZ SE & Co. KG Company Information
11.9.2 KARL STORZ SE & Co. KG Lung Biopsy Systems Product Offered
11.9.3 KARL STORZ SE & Co. KG Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 KARL STORZ SE & Co. KG Main Business Overview
11.9.5 KARL STORZ SE & Co. KG Latest Developments
11.10 Technowood Co., Ltd.
11.10.1 Technowood Co., Ltd. Company Information
11.10.2 Technowood Co., Ltd. Lung Biopsy Systems Product Offered
11.10.3 Technowood Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Technowood Co., Ltd. Main Business Overview
11.10.5 Technowood Co., Ltd. Latest Developments
11.11 Sumitomo Bakelite Co., Ltd.
11.11.1 Sumitomo Bakelite Co., Ltd. Company Information
11.11.2 Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Product Offered
11.11.3 Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Sumitomo Bakelite Co., Ltd. Main Business Overview
11.11.5 Sumitomo Bakelite Co., Ltd. Latest Developments
11.12 HOYA Corporation (PENTAX Medical)
11.12.1 HOYA Corporation (PENTAX Medical) Company Information
11.12.2 HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Product Offered
11.12.3 HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 HOYA Corporation (PENTAX Medical) Main Business Overview
11.12.5 HOYA Corporation (PENTAX Medical) Latest Developments
11.13 FINEMEDIX CO., LTD.
11.13.1 FINEMEDIX CO., LTD. Company Information
11.13.2 FINEMEDIX CO., LTD. Lung Biopsy Systems Product Offered
11.13.3 FINEMEDIX CO., LTD. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 FINEMEDIX CO., LTD. Main Business Overview
11.13.5 FINEMEDIX CO., LTD. Latest Developments
11.14 Upex-Med Corp.
11.14.1 Upex-Med Corp. Company Information
11.14.2 Upex-Med Corp. Lung Biopsy Systems Product Offered
11.14.3 Upex-Med Corp. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Upex-Med Corp. Main Business Overview
11.14.5 Upex-Med Corp. Latest Developments
11.15 Medcare Medical (Medcare Medical Co., Ltd.)
11.15.1 Medcare Medical (Medcare Medical Co., Ltd.) Company Information
11.15.2 Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Product Offered
11.15.3 Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Medcare Medical (Medcare Medical Co., Ltd.) Main Business Overview
11.15.5 Medcare Medical (Medcare Medical Co., Ltd.) Latest Developments
11.16 Argon Medical Devices, Inc.
11.16.1 Argon Medical Devices, Inc. Company Information
11.16.2 Argon Medical Devices, Inc. Lung Biopsy Systems Product Offered
11.16.3 Argon Medical Devices, Inc. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Argon Medical Devices, Inc. Main Business Overview
11.16.5 Argon Medical Devices, Inc. Latest Developments
11.17 Becton, Dickinson and Company (BD)
11.17.1 Becton, Dickinson and Company (BD) Company Information
11.17.2 Becton, Dickinson and Company (BD) Lung Biopsy Systems Product Offered
11.17.3 Becton, Dickinson and Company (BD) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Becton, Dickinson and Company (BD) Main Business Overview
11.17.5 Becton, Dickinson and Company (BD) Latest Developments
11.18 Hunan Vathin Medical Instrument Co., Ltd.
11.18.1 Hunan Vathin Medical Instrument Co., Ltd. Company Information
11.18.2 Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Product Offered
11.18.3 Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Hunan Vathin Medical Instrument Co., Ltd. Main Business Overview
11.18.5 Hunan Vathin Medical Instrument Co., Ltd. Latest Developments
11.19 Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
11.19.1 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Company Information
11.19.2 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Product Offered
11.19.3 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Main Business Overview
11.19.5 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Latest Developments
11.20 SonoScape Medical Corp.
11.20.1 SonoScape Medical Corp. Company Information
11.20.2 SonoScape Medical Corp. Lung Biopsy Systems Product Offered
11.20.3 SonoScape Medical Corp. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 SonoScape Medical Corp. Main Business Overview
11.20.5 SonoScape Medical Corp. Latest Developments
11.21 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
11.21.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Company Information
11.21.2 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Product Offered
11.21.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Main Business Overview
11.21.5 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Latest Developments
11.22 Jiangsu Vedkang Medical Science and Technology Co., Ltd.
11.22.1 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Company Information
11.22.2 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Product Offered
11.22.3 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Main Business Overview
11.22.5 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Latest Developments
11.23 Zhuji Peng Tian Medical Instrument Co.,Ltd
11.23.1 Zhuji Peng Tian Medical Instrument Co.,Ltd Company Information
11.23.2 Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Product Offered
11.23.3 Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Zhuji Peng Tian Medical Instrument Co.,Ltd Main Business Overview
11.23.5 Zhuji Peng Tian Medical Instrument Co.,Ltd Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lung Biopsy Systems Market Size (2021-2032)
2.1.2 Lung Biopsy Systems Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Lung Biopsy Systems by Country/Region (2021, 2025 & 2032)
2.2 Lung Biopsy Systems Segment by Type
2.2.1 Needle Biopsy
2.2.2 Thoracoscopic Biopsy
2.2.3 Transbronchial Biopsy
2.2.4 Lung Biopsy Systems Market Size by Type
2.2.4.1 Lung Biopsy Systems Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Lung Biopsy Systems Market Size Market Share by Type (2021-2026)
2.3 Lung Biopsy Systems Segment by Access Route
2.3.1 Bronchoscopic
2.3.2 Percutaneous
2.3.3 Lung Biopsy Systems Market Size by Access Route
2.3.3.1 Lung Biopsy Systems Market Size CAGR by Access Route (2021 VS 2025 VS 2032)
2.3.3.2 Global Lung Biopsy Systems Market Size Market Share by Access Route (2021-2026)
2.4 Lung Biopsy Systems Segment by Navigation Modality
2.4.1 No Navigation
2.4.2 Electromagnetic Navigation
2.4.3 Robotic Navigation
2.4.4 Shape Sensing
2.4.5 Lung Biopsy Systems Market Size by Navigation Modality
2.4.5.1 Lung Biopsy Systems Market Size CAGR by Navigation Modality (2021 VS 2025 VS 2032)
2.4.5.2 Global Lung Biopsy Systems Market Size Market Share by Navigation Modality (2021-2026)
2.5 Lung Biopsy Systems Segment by Application
2.5.1 Hospitals
2.5.2 Cancer Research Centers
2.5.3 Specialty Clinics
2.5.4 Others
2.5.5 Lung Biopsy Systems Market Size by Application
2.5.5.1 Lung Biopsy Systems Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Lung Biopsy Systems Market Size Market Share by Application (2021-2026)
3 LUNG BIOPSY SYSTEMS MARKET SIZE BY PLAYER
3.1 Lung Biopsy Systems Market Size Market Share by Player
3.1.1 Global Lung Biopsy Systems Revenue by Player (2021-2026)
3.1.2 Global Lung Biopsy Systems Revenue Market Share by Player (2021-2026)
3.2 Global Lung Biopsy Systems Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LUNG BIOPSY SYSTEMS BY REGION
4.1 Lung Biopsy Systems Market Size by Region (2021-2026)
4.2 Global Lung Biopsy Systems Annual Revenue by Country/Region (2021-2026)
4.3 Americas Lung Biopsy Systems Market Size Growth (2021-2026)
4.4 APAC Lung Biopsy Systems Market Size Growth (2021-2026)
4.5 Europe Lung Biopsy Systems Market Size Growth (2021-2026)
4.6 Middle East & Africa Lung Biopsy Systems Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Lung Biopsy Systems Market Size by Country (2021-2026)
5.2 Americas Lung Biopsy Systems Market Size by Type (2021-2026)
5.3 Americas Lung Biopsy Systems Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lung Biopsy Systems Market Size by Region (2021-2026)
6.2 APAC Lung Biopsy Systems Market Size by Type (2021-2026)
6.3 APAC Lung Biopsy Systems Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Lung Biopsy Systems Market Size by Country (2021-2026)
7.2 Europe Lung Biopsy Systems Market Size by Type (2021-2026)
7.3 Europe Lung Biopsy Systems Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lung Biopsy Systems by Region (2021-2026)
8.2 Middle East & Africa Lung Biopsy Systems Market Size by Type (2021-2026)
8.3 Middle East & Africa Lung Biopsy Systems Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LUNG BIOPSY SYSTEMS MARKET FORECAST
10.1 Global Lung Biopsy Systems Forecast by Region (2027-2032)
10.1.1 Global Lung Biopsy Systems Forecast by Region (2027-2032)
10.1.2 Americas Lung Biopsy Systems Forecast
10.1.3 APAC Lung Biopsy Systems Forecast
10.1.4 Europe Lung Biopsy Systems Forecast
10.1.5 Middle East & Africa Lung Biopsy Systems Forecast
10.2 Americas Lung Biopsy Systems Forecast by Country (2027-2032)
10.2.1 United States Market Lung Biopsy Systems Forecast
10.2.2 Canada Market Lung Biopsy Systems Forecast
10.2.3 Mexico Market Lung Biopsy Systems Forecast
10.2.4 Brazil Market Lung Biopsy Systems Forecast
10.3 APAC Lung Biopsy Systems Forecast by Region (2027-2032)
10.3.1 China Lung Biopsy Systems Market Forecast
10.3.2 Japan Market Lung Biopsy Systems Forecast
10.3.3 Korea Market Lung Biopsy Systems Forecast
10.3.4 Southeast Asia Market Lung Biopsy Systems Forecast
10.3.5 India Market Lung Biopsy Systems Forecast
10.3.6 Australia Market Lung Biopsy Systems Forecast
10.4 Europe Lung Biopsy Systems Forecast by Country (2027-2032)
10.4.1 Germany Market Lung Biopsy Systems Forecast
10.4.2 France Market Lung Biopsy Systems Forecast
10.4.3 UK Market Lung Biopsy Systems Forecast
10.4.4 Italy Market Lung Biopsy Systems Forecast
10.4.5 Russia Market Lung Biopsy Systems Forecast
10.5 Middle East & Africa Lung Biopsy Systems Forecast by Region (2027-2032)
10.5.1 Egypt Market Lung Biopsy Systems Forecast
10.5.2 South Africa Market Lung Biopsy Systems Forecast
10.5.3 Israel Market Lung Biopsy Systems Forecast
10.5.4 Turkey Market Lung Biopsy Systems Forecast
10.6 Global Lung Biopsy Systems Forecast by Type (2027-2032)
10.7 Global Lung Biopsy Systems Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Lung Biopsy Systems Forecast
11 KEY PLAYERS ANALYSIS
11.1 Intuitive Surgical, Inc.
11.1.1 Intuitive Surgical, Inc. Company Information
11.1.2 Intuitive Surgical, Inc. Lung Biopsy Systems Product Offered
11.1.3 Intuitive Surgical, Inc. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Intuitive Surgical, Inc. Main Business Overview
11.1.5 Intuitive Surgical, Inc. Latest Developments
11.2 Johnson & Johnson MedTech (Ethicon)
11.2.1 Johnson & Johnson MedTech (Ethicon) Company Information
11.2.2 Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Product Offered
11.2.3 Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Johnson & Johnson MedTech (Ethicon) Main Business Overview
11.2.5 Johnson & Johnson MedTech (Ethicon) Latest Developments
11.3 Medtronic plc
11.3.1 Medtronic plc Company Information
11.3.2 Medtronic plc Lung Biopsy Systems Product Offered
11.3.3 Medtronic plc Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Medtronic plc Main Business Overview
11.3.5 Medtronic plc Latest Developments
11.4 Olympus Corporation
11.4.1 Olympus Corporation Company Information
11.4.2 Olympus Corporation Lung Biopsy Systems Product Offered
11.4.3 Olympus Corporation Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Olympus Corporation Main Business Overview
11.4.5 Olympus Corporation Latest Developments
11.5 ERBE Elektromedizin GmbH
11.5.1 ERBE Elektromedizin GmbH Company Information
11.5.2 ERBE Elektromedizin GmbH Lung Biopsy Systems Product Offered
11.5.3 ERBE Elektromedizin GmbH Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 ERBE Elektromedizin GmbH Main Business Overview
11.5.5 ERBE Elektromedizin GmbH Latest Developments
11.6 Ambu A/S
11.6.1 Ambu A/S Company Information
11.6.2 Ambu A/S Lung Biopsy Systems Product Offered
11.6.3 Ambu A/S Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Ambu A/S Main Business Overview
11.6.5 Ambu A/S Latest Developments
11.7 Boston Scientific Corporation
11.7.1 Boston Scientific Corporation Company Information
11.7.2 Boston Scientific Corporation Lung Biopsy Systems Product Offered
11.7.3 Boston Scientific Corporation Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Boston Scientific Corporation Main Business Overview
11.7.5 Boston Scientific Corporation Latest Developments
11.8 Cook Medical LLC
11.8.1 Cook Medical LLC Company Information
11.8.2 Cook Medical LLC Lung Biopsy Systems Product Offered
11.8.3 Cook Medical LLC Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Cook Medical LLC Main Business Overview
11.8.5 Cook Medical LLC Latest Developments
11.9 KARL STORZ SE & Co. KG
11.9.1 KARL STORZ SE & Co. KG Company Information
11.9.2 KARL STORZ SE & Co. KG Lung Biopsy Systems Product Offered
11.9.3 KARL STORZ SE & Co. KG Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 KARL STORZ SE & Co. KG Main Business Overview
11.9.5 KARL STORZ SE & Co. KG Latest Developments
11.10 Technowood Co., Ltd.
11.10.1 Technowood Co., Ltd. Company Information
11.10.2 Technowood Co., Ltd. Lung Biopsy Systems Product Offered
11.10.3 Technowood Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Technowood Co., Ltd. Main Business Overview
11.10.5 Technowood Co., Ltd. Latest Developments
11.11 Sumitomo Bakelite Co., Ltd.
11.11.1 Sumitomo Bakelite Co., Ltd. Company Information
11.11.2 Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Product Offered
11.11.3 Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Sumitomo Bakelite Co., Ltd. Main Business Overview
11.11.5 Sumitomo Bakelite Co., Ltd. Latest Developments
11.12 HOYA Corporation (PENTAX Medical)
11.12.1 HOYA Corporation (PENTAX Medical) Company Information
11.12.2 HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Product Offered
11.12.3 HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 HOYA Corporation (PENTAX Medical) Main Business Overview
11.12.5 HOYA Corporation (PENTAX Medical) Latest Developments
11.13 FINEMEDIX CO., LTD.
11.13.1 FINEMEDIX CO., LTD. Company Information
11.13.2 FINEMEDIX CO., LTD. Lung Biopsy Systems Product Offered
11.13.3 FINEMEDIX CO., LTD. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 FINEMEDIX CO., LTD. Main Business Overview
11.13.5 FINEMEDIX CO., LTD. Latest Developments
11.14 Upex-Med Corp.
11.14.1 Upex-Med Corp. Company Information
11.14.2 Upex-Med Corp. Lung Biopsy Systems Product Offered
11.14.3 Upex-Med Corp. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Upex-Med Corp. Main Business Overview
11.14.5 Upex-Med Corp. Latest Developments
11.15 Medcare Medical (Medcare Medical Co., Ltd.)
11.15.1 Medcare Medical (Medcare Medical Co., Ltd.) Company Information
11.15.2 Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Product Offered
11.15.3 Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Medcare Medical (Medcare Medical Co., Ltd.) Main Business Overview
11.15.5 Medcare Medical (Medcare Medical Co., Ltd.) Latest Developments
11.16 Argon Medical Devices, Inc.
11.16.1 Argon Medical Devices, Inc. Company Information
11.16.2 Argon Medical Devices, Inc. Lung Biopsy Systems Product Offered
11.16.3 Argon Medical Devices, Inc. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Argon Medical Devices, Inc. Main Business Overview
11.16.5 Argon Medical Devices, Inc. Latest Developments
11.17 Becton, Dickinson and Company (BD)
11.17.1 Becton, Dickinson and Company (BD) Company Information
11.17.2 Becton, Dickinson and Company (BD) Lung Biopsy Systems Product Offered
11.17.3 Becton, Dickinson and Company (BD) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Becton, Dickinson and Company (BD) Main Business Overview
11.17.5 Becton, Dickinson and Company (BD) Latest Developments
11.18 Hunan Vathin Medical Instrument Co., Ltd.
11.18.1 Hunan Vathin Medical Instrument Co., Ltd. Company Information
11.18.2 Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Product Offered
11.18.3 Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Hunan Vathin Medical Instrument Co., Ltd. Main Business Overview
11.18.5 Hunan Vathin Medical Instrument Co., Ltd. Latest Developments
11.19 Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
11.19.1 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Company Information
11.19.2 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Product Offered
11.19.3 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Main Business Overview
11.19.5 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Latest Developments
11.20 SonoScape Medical Corp.
11.20.1 SonoScape Medical Corp. Company Information
11.20.2 SonoScape Medical Corp. Lung Biopsy Systems Product Offered
11.20.3 SonoScape Medical Corp. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 SonoScape Medical Corp. Main Business Overview
11.20.5 SonoScape Medical Corp. Latest Developments
11.21 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
11.21.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Company Information
11.21.2 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Product Offered
11.21.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Main Business Overview
11.21.5 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Latest Developments
11.22 Jiangsu Vedkang Medical Science and Technology Co., Ltd.
11.22.1 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Company Information
11.22.2 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Product Offered
11.22.3 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Main Business Overview
11.22.5 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Latest Developments
11.23 Zhuji Peng Tian Medical Instrument Co.,Ltd
11.23.1 Zhuji Peng Tian Medical Instrument Co.,Ltd Company Information
11.23.2 Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Product Offered
11.23.3 Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Zhuji Peng Tian Medical Instrument Co.,Ltd Main Business Overview
11.23.5 Zhuji Peng Tian Medical Instrument Co.,Ltd Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Lung Biopsy Systems Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Lung Biopsy Systems Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Needle Biopsy
Table 4. Major Players of Thoracoscopic Biopsy
Table 5. Major Players of Transbronchial Biopsy
Table 6. Lung Biopsy Systems Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Lung Biopsy Systems Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Lung Biopsy Systems Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Bronchoscopic
Table 10. Major Players of Percutaneous
Table 11. Lung Biopsy Systems Market Size CAGR by Access Route (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Lung Biopsy Systems Market Size by Access Route (2021-2026) & ($ millions)
Table 13. Global Lung Biopsy Systems Market Size Market Share by Access Route (2021-2026)
Table 14. Major Players of No Navigation
Table 15. Major Players of Electromagnetic Navigation
Table 16. Major Players of Robotic Navigation
Table 17. Major Players of Shape Sensing
Table 18. Lung Biopsy Systems Market Size CAGR by Navigation Modality (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Lung Biopsy Systems Market Size by Navigation Modality (2021-2026) & ($ millions)
Table 20. Global Lung Biopsy Systems Market Size Market Share by Navigation Modality (2021-2026)
Table 21. Lung Biopsy Systems Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Lung Biopsy Systems Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Lung Biopsy Systems Market Size Market Share by Application (2021-2026)
Table 24. Global Lung Biopsy Systems Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Lung Biopsy Systems Revenue Market Share by Player (2021-2026)
Table 26. Lung Biopsy Systems Key Players Head office and Products Offered
Table 27. Lung Biopsy Systems Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Lung Biopsy Systems Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Lung Biopsy Systems Market Size Market Share by Region (2021-2026)
Table 32. Global Lung Biopsy Systems Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Lung Biopsy Systems Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Lung Biopsy Systems Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Lung Biopsy Systems Market Size Market Share by Country (2021-2026)
Table 36. Americas Lung Biopsy Systems Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Lung Biopsy Systems Market Size Market Share by Type (2021-2026)
Table 38. Americas Lung Biopsy Systems Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Lung Biopsy Systems Market Size Market Share by Application (2021-2026)
Table 40. APAC Lung Biopsy Systems Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Lung Biopsy Systems Market Size Market Share by Region (2021-2026)
Table 42. APAC Lung Biopsy Systems Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Lung Biopsy Systems Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Lung Biopsy Systems Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Lung Biopsy Systems Market Size Market Share by Country (2021-2026)
Table 46. Europe Lung Biopsy Systems Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Lung Biopsy Systems Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Lung Biopsy Systems Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Lung Biopsy Systems Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Lung Biopsy Systems Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Lung Biopsy Systems
Table 52. Key Market Challenges & Risks of Lung Biopsy Systems
Table 53. Key Industry Trends of Lung Biopsy Systems
Table 54. Global Lung Biopsy Systems Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Lung Biopsy Systems Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Lung Biopsy Systems Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Lung Biopsy Systems Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Intuitive Surgical, Inc. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 59. Intuitive Surgical, Inc. Lung Biopsy Systems Product Offered
Table 60. Intuitive Surgical, Inc. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Intuitive Surgical, Inc. Main Business
Table 62. Intuitive Surgical, Inc. Latest Developments
Table 63. Johnson & Johnson MedTech (Ethicon) Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 64. Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Product Offered
Table 65. Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Johnson & Johnson MedTech (Ethicon) Main Business
Table 67. Johnson & Johnson MedTech (Ethicon) Latest Developments
Table 68. Medtronic plc Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 69. Medtronic plc Lung Biopsy Systems Product Offered
Table 70. Medtronic plc Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Medtronic plc Main Business
Table 72. Medtronic plc Latest Developments
Table 73. Olympus Corporation Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 74. Olympus Corporation Lung Biopsy Systems Product Offered
Table 75. Olympus Corporation Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Olympus Corporation Main Business
Table 77. Olympus Corporation Latest Developments
Table 78. ERBE Elektromedizin GmbH Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 79. ERBE Elektromedizin GmbH Lung Biopsy Systems Product Offered
Table 80. ERBE Elektromedizin GmbH Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. ERBE Elektromedizin GmbH Main Business
Table 82. ERBE Elektromedizin GmbH Latest Developments
Table 83. Ambu A/S Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 84. Ambu A/S Lung Biopsy Systems Product Offered
Table 85. Ambu A/S Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Ambu A/S Main Business
Table 87. Ambu A/S Latest Developments
Table 88. Boston Scientific Corporation Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 89. Boston Scientific Corporation Lung Biopsy Systems Product Offered
Table 90. Boston Scientific Corporation Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Boston Scientific Corporation Main Business
Table 92. Boston Scientific Corporation Latest Developments
Table 93. Cook Medical LLC Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 94. Cook Medical LLC Lung Biopsy Systems Product Offered
Table 95. Cook Medical LLC Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Cook Medical LLC Main Business
Table 97. Cook Medical LLC Latest Developments
Table 98. KARL STORZ SE & Co. KG Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 99. KARL STORZ SE & Co. KG Lung Biopsy Systems Product Offered
Table 100. KARL STORZ SE & Co. KG Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. KARL STORZ SE & Co. KG Main Business
Table 102. KARL STORZ SE & Co. KG Latest Developments
Table 103. Technowood Co., Ltd. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 104. Technowood Co., Ltd. Lung Biopsy Systems Product Offered
Table 105. Technowood Co., Ltd. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Technowood Co., Ltd. Main Business
Table 107. Technowood Co., Ltd. Latest Developments
Table 108. Sumitomo Bakelite Co., Ltd. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 109. Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Product Offered
Table 110. Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Sumitomo Bakelite Co., Ltd. Main Business
Table 112. Sumitomo Bakelite Co., Ltd. Latest Developments
Table 113. HOYA Corporation (PENTAX Medical) Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 114. HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Product Offered
Table 115. HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. HOYA Corporation (PENTAX Medical) Main Business
Table 117. HOYA Corporation (PENTAX Medical) Latest Developments
Table 118. FINEMEDIX CO., LTD. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 119. FINEMEDIX CO., LTD. Lung Biopsy Systems Product Offered
Table 120. FINEMEDIX CO., LTD. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. FINEMEDIX CO., LTD. Main Business
Table 122. FINEMEDIX CO., LTD. Latest Developments
Table 123. Upex-Med Corp. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 124. Upex-Med Corp. Lung Biopsy Systems Product Offered
Table 125. Upex-Med Corp. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Upex-Med Corp. Main Business
Table 127. Upex-Med Corp. Latest Developments
Table 128. Medcare Medical (Medcare Medical Co., Ltd.) Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 129. Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Product Offered
Table 130. Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Medcare Medical (Medcare Medical Co., Ltd.) Main Business
Table 132. Medcare Medical (Medcare Medical Co., Ltd.) Latest Developments
Table 133. Argon Medical Devices, Inc. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 134. Argon Medical Devices, Inc. Lung Biopsy Systems Product Offered
Table 135. Argon Medical Devices, Inc. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Argon Medical Devices, Inc. Main Business
Table 137. Argon Medical Devices, Inc. Latest Developments
Table 138. Becton, Dickinson and Company (BD) Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 139. Becton, Dickinson and Company (BD) Lung Biopsy Systems Product Offered
Table 140. Becton, Dickinson and Company (BD) Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. Becton, Dickinson and Company (BD) Main Business
Table 142. Becton, Dickinson and Company (BD) Latest Developments
Table 143. Hunan Vathin Medical Instrument Co., Ltd. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 144. Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Product Offered
Table 145. Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Hunan Vathin Medical Instrument Co., Ltd. Main Business
Table 147. Hunan Vathin Medical Instrument Co., Ltd. Latest Developments
Table 148. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 149. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Product Offered
Table 150. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Main Business
Table 152. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Latest Developments
Table 153. SonoScape Medical Corp. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 154. SonoScape Medical Corp. Lung Biopsy Systems Product Offered
Table 155. SonoScape Medical Corp. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 156. SonoScape Medical Corp. Main Business
Table 157. SonoScape Medical Corp. Latest Developments
Table 158. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 159. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Product Offered
Table 160. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 161. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Main Business
Table 162. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Latest Developments
Table 163. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 164. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Product Offered
Table 165. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 166. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Main Business
Table 167. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Latest Developments
Table 168. Zhuji Peng Tian Medical Instrument Co.,Ltd Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 169. Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Product Offered
Table 170. Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 171. Zhuji Peng Tian Medical Instrument Co.,Ltd Main Business
Table 172. Zhuji Peng Tian Medical Instrument Co.,Ltd Latest Developments
Table 1. Lung Biopsy Systems Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Lung Biopsy Systems Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Needle Biopsy
Table 4. Major Players of Thoracoscopic Biopsy
Table 5. Major Players of Transbronchial Biopsy
Table 6. Lung Biopsy Systems Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Lung Biopsy Systems Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Lung Biopsy Systems Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Bronchoscopic
Table 10. Major Players of Percutaneous
Table 11. Lung Biopsy Systems Market Size CAGR by Access Route (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Lung Biopsy Systems Market Size by Access Route (2021-2026) & ($ millions)
Table 13. Global Lung Biopsy Systems Market Size Market Share by Access Route (2021-2026)
Table 14. Major Players of No Navigation
Table 15. Major Players of Electromagnetic Navigation
Table 16. Major Players of Robotic Navigation
Table 17. Major Players of Shape Sensing
Table 18. Lung Biopsy Systems Market Size CAGR by Navigation Modality (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Lung Biopsy Systems Market Size by Navigation Modality (2021-2026) & ($ millions)
Table 20. Global Lung Biopsy Systems Market Size Market Share by Navigation Modality (2021-2026)
Table 21. Lung Biopsy Systems Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Lung Biopsy Systems Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Lung Biopsy Systems Market Size Market Share by Application (2021-2026)
Table 24. Global Lung Biopsy Systems Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Lung Biopsy Systems Revenue Market Share by Player (2021-2026)
Table 26. Lung Biopsy Systems Key Players Head office and Products Offered
Table 27. Lung Biopsy Systems Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Lung Biopsy Systems Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Lung Biopsy Systems Market Size Market Share by Region (2021-2026)
Table 32. Global Lung Biopsy Systems Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Lung Biopsy Systems Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Lung Biopsy Systems Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Lung Biopsy Systems Market Size Market Share by Country (2021-2026)
Table 36. Americas Lung Biopsy Systems Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Lung Biopsy Systems Market Size Market Share by Type (2021-2026)
Table 38. Americas Lung Biopsy Systems Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Lung Biopsy Systems Market Size Market Share by Application (2021-2026)
Table 40. APAC Lung Biopsy Systems Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Lung Biopsy Systems Market Size Market Share by Region (2021-2026)
Table 42. APAC Lung Biopsy Systems Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Lung Biopsy Systems Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Lung Biopsy Systems Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Lung Biopsy Systems Market Size Market Share by Country (2021-2026)
Table 46. Europe Lung Biopsy Systems Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Lung Biopsy Systems Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Lung Biopsy Systems Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Lung Biopsy Systems Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Lung Biopsy Systems Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Lung Biopsy Systems
Table 52. Key Market Challenges & Risks of Lung Biopsy Systems
Table 53. Key Industry Trends of Lung Biopsy Systems
Table 54. Global Lung Biopsy Systems Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Lung Biopsy Systems Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Lung Biopsy Systems Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Lung Biopsy Systems Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Intuitive Surgical, Inc. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 59. Intuitive Surgical, Inc. Lung Biopsy Systems Product Offered
Table 60. Intuitive Surgical, Inc. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Intuitive Surgical, Inc. Main Business
Table 62. Intuitive Surgical, Inc. Latest Developments
Table 63. Johnson & Johnson MedTech (Ethicon) Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 64. Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Product Offered
Table 65. Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Johnson & Johnson MedTech (Ethicon) Main Business
Table 67. Johnson & Johnson MedTech (Ethicon) Latest Developments
Table 68. Medtronic plc Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 69. Medtronic plc Lung Biopsy Systems Product Offered
Table 70. Medtronic plc Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Medtronic plc Main Business
Table 72. Medtronic plc Latest Developments
Table 73. Olympus Corporation Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 74. Olympus Corporation Lung Biopsy Systems Product Offered
Table 75. Olympus Corporation Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Olympus Corporation Main Business
Table 77. Olympus Corporation Latest Developments
Table 78. ERBE Elektromedizin GmbH Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 79. ERBE Elektromedizin GmbH Lung Biopsy Systems Product Offered
Table 80. ERBE Elektromedizin GmbH Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. ERBE Elektromedizin GmbH Main Business
Table 82. ERBE Elektromedizin GmbH Latest Developments
Table 83. Ambu A/S Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 84. Ambu A/S Lung Biopsy Systems Product Offered
Table 85. Ambu A/S Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Ambu A/S Main Business
Table 87. Ambu A/S Latest Developments
Table 88. Boston Scientific Corporation Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 89. Boston Scientific Corporation Lung Biopsy Systems Product Offered
Table 90. Boston Scientific Corporation Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Boston Scientific Corporation Main Business
Table 92. Boston Scientific Corporation Latest Developments
Table 93. Cook Medical LLC Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 94. Cook Medical LLC Lung Biopsy Systems Product Offered
Table 95. Cook Medical LLC Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Cook Medical LLC Main Business
Table 97. Cook Medical LLC Latest Developments
Table 98. KARL STORZ SE & Co. KG Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 99. KARL STORZ SE & Co. KG Lung Biopsy Systems Product Offered
Table 100. KARL STORZ SE & Co. KG Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. KARL STORZ SE & Co. KG Main Business
Table 102. KARL STORZ SE & Co. KG Latest Developments
Table 103. Technowood Co., Ltd. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 104. Technowood Co., Ltd. Lung Biopsy Systems Product Offered
Table 105. Technowood Co., Ltd. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Technowood Co., Ltd. Main Business
Table 107. Technowood Co., Ltd. Latest Developments
Table 108. Sumitomo Bakelite Co., Ltd. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 109. Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Product Offered
Table 110. Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Sumitomo Bakelite Co., Ltd. Main Business
Table 112. Sumitomo Bakelite Co., Ltd. Latest Developments
Table 113. HOYA Corporation (PENTAX Medical) Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 114. HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Product Offered
Table 115. HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. HOYA Corporation (PENTAX Medical) Main Business
Table 117. HOYA Corporation (PENTAX Medical) Latest Developments
Table 118. FINEMEDIX CO., LTD. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 119. FINEMEDIX CO., LTD. Lung Biopsy Systems Product Offered
Table 120. FINEMEDIX CO., LTD. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. FINEMEDIX CO., LTD. Main Business
Table 122. FINEMEDIX CO., LTD. Latest Developments
Table 123. Upex-Med Corp. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 124. Upex-Med Corp. Lung Biopsy Systems Product Offered
Table 125. Upex-Med Corp. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Upex-Med Corp. Main Business
Table 127. Upex-Med Corp. Latest Developments
Table 128. Medcare Medical (Medcare Medical Co., Ltd.) Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 129. Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Product Offered
Table 130. Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Medcare Medical (Medcare Medical Co., Ltd.) Main Business
Table 132. Medcare Medical (Medcare Medical Co., Ltd.) Latest Developments
Table 133. Argon Medical Devices, Inc. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 134. Argon Medical Devices, Inc. Lung Biopsy Systems Product Offered
Table 135. Argon Medical Devices, Inc. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Argon Medical Devices, Inc. Main Business
Table 137. Argon Medical Devices, Inc. Latest Developments
Table 138. Becton, Dickinson and Company (BD) Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 139. Becton, Dickinson and Company (BD) Lung Biopsy Systems Product Offered
Table 140. Becton, Dickinson and Company (BD) Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. Becton, Dickinson and Company (BD) Main Business
Table 142. Becton, Dickinson and Company (BD) Latest Developments
Table 143. Hunan Vathin Medical Instrument Co., Ltd. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 144. Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Product Offered
Table 145. Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Hunan Vathin Medical Instrument Co., Ltd. Main Business
Table 147. Hunan Vathin Medical Instrument Co., Ltd. Latest Developments
Table 148. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 149. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Product Offered
Table 150. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Main Business
Table 152. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Latest Developments
Table 153. SonoScape Medical Corp. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 154. SonoScape Medical Corp. Lung Biopsy Systems Product Offered
Table 155. SonoScape Medical Corp. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 156. SonoScape Medical Corp. Main Business
Table 157. SonoScape Medical Corp. Latest Developments
Table 158. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 159. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Product Offered
Table 160. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 161. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Main Business
Table 162. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Latest Developments
Table 163. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 164. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Product Offered
Table 165. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 166. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Main Business
Table 167. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Latest Developments
Table 168. Zhuji Peng Tian Medical Instrument Co.,Ltd Details, Company Type, Lung Biopsy Systems Area Served and Its Competitors
Table 169. Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Product Offered
Table 170. Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 171. Zhuji Peng Tian Medical Instrument Co.,Ltd Main Business
Table 172. Zhuji Peng Tian Medical Instrument Co.,Ltd Latest Developments
LIST OF FIGURES
Figure 1. Lung Biopsy Systems Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lung Biopsy Systems Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Lung Biopsy Systems Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Lung Biopsy Systems Sales Market Share by Country/Region (2025)
Figure 8. Lung Biopsy Systems Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Lung Biopsy Systems Market Size Market Share by Type in 2025
Figure 10. Global Lung Biopsy Systems Market Size Market Share by Access Route in 2025
Figure 11. Global Lung Biopsy Systems Market Size Market Share by Navigation Modality in 2025
Figure 12. Lung Biopsy Systems in Hospitals
Figure 13. Global Lung Biopsy Systems Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Lung Biopsy Systems in Cancer Research Centers
Figure 15. Global Lung Biopsy Systems Market: Cancer Research Centers (2021-2026) & ($ millions)
Figure 16. Lung Biopsy Systems in Specialty Clinics
Figure 17. Global Lung Biopsy Systems Market: Specialty Clinics (2021-2026) & ($ millions)
Figure 18. Lung Biopsy Systems in Others
Figure 19. Global Lung Biopsy Systems Market: Others (2021-2026) & ($ millions)
Figure 20. Global Lung Biopsy Systems Market Size Market Share by Application in 2025
Figure 21. Global Lung Biopsy Systems Revenue Market Share by Player in 2025
Figure 22. Global Lung Biopsy Systems Market Size Market Share by Region (2021-2026)
Figure 23. Americas Lung Biopsy Systems Market Size 2021-2026 ($ millions)
Figure 24. APAC Lung Biopsy Systems Market Size 2021-2026 ($ millions)
Figure 25. Europe Lung Biopsy Systems Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Lung Biopsy Systems Market Size 2021-2026 ($ millions)
Figure 27. Americas Lung Biopsy Systems Value Market Share by Country in 2025
Figure 28. United States Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Lung Biopsy Systems Market Size Market Share by Region in 2025
Figure 33. APAC Lung Biopsy Systems Market Size Market Share by Type (2021-2026)
Figure 34. APAC Lung Biopsy Systems Market Size Market Share by Application (2021-2026)
Figure 35. China Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 39. India Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Lung Biopsy Systems Market Size Market Share by Country in 2025
Figure 42. Europe Lung Biopsy Systems Market Size Market Share by Type (2021-2026)
Figure 43. Europe Lung Biopsy Systems Market Size Market Share by Application (2021-2026)
Figure 44. Germany Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 45. France Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Lung Biopsy Systems Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Lung Biopsy Systems Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Lung Biopsy Systems Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 58. APAC Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 59. Europe Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 61. United States Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 62. Canada Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 63. Mexico Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 64. Brazil Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 65. China Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 66. Japan Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 67. Korea Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 69. India Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 70. Australia Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 71. Germany Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 72. France Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 73. UK Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 74. Italy Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 75. Russia Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 76. Egypt Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 77. South Africa Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 78. Israel Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 79. Turkey Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 80. Global Lung Biopsy Systems Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Lung Biopsy Systems Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 1. Lung Biopsy Systems Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lung Biopsy Systems Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Lung Biopsy Systems Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Lung Biopsy Systems Sales Market Share by Country/Region (2025)
Figure 8. Lung Biopsy Systems Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Lung Biopsy Systems Market Size Market Share by Type in 2025
Figure 10. Global Lung Biopsy Systems Market Size Market Share by Access Route in 2025
Figure 11. Global Lung Biopsy Systems Market Size Market Share by Navigation Modality in 2025
Figure 12. Lung Biopsy Systems in Hospitals
Figure 13. Global Lung Biopsy Systems Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Lung Biopsy Systems in Cancer Research Centers
Figure 15. Global Lung Biopsy Systems Market: Cancer Research Centers (2021-2026) & ($ millions)
Figure 16. Lung Biopsy Systems in Specialty Clinics
Figure 17. Global Lung Biopsy Systems Market: Specialty Clinics (2021-2026) & ($ millions)
Figure 18. Lung Biopsy Systems in Others
Figure 19. Global Lung Biopsy Systems Market: Others (2021-2026) & ($ millions)
Figure 20. Global Lung Biopsy Systems Market Size Market Share by Application in 2025
Figure 21. Global Lung Biopsy Systems Revenue Market Share by Player in 2025
Figure 22. Global Lung Biopsy Systems Market Size Market Share by Region (2021-2026)
Figure 23. Americas Lung Biopsy Systems Market Size 2021-2026 ($ millions)
Figure 24. APAC Lung Biopsy Systems Market Size 2021-2026 ($ millions)
Figure 25. Europe Lung Biopsy Systems Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Lung Biopsy Systems Market Size 2021-2026 ($ millions)
Figure 27. Americas Lung Biopsy Systems Value Market Share by Country in 2025
Figure 28. United States Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Lung Biopsy Systems Market Size Market Share by Region in 2025
Figure 33. APAC Lung Biopsy Systems Market Size Market Share by Type (2021-2026)
Figure 34. APAC Lung Biopsy Systems Market Size Market Share by Application (2021-2026)
Figure 35. China Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 39. India Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Lung Biopsy Systems Market Size Market Share by Country in 2025
Figure 42. Europe Lung Biopsy Systems Market Size Market Share by Type (2021-2026)
Figure 43. Europe Lung Biopsy Systems Market Size Market Share by Application (2021-2026)
Figure 44. Germany Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 45. France Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Lung Biopsy Systems Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Lung Biopsy Systems Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Lung Biopsy Systems Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Lung Biopsy Systems Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 58. APAC Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 59. Europe Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 61. United States Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 62. Canada Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 63. Mexico Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 64. Brazil Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 65. China Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 66. Japan Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 67. Korea Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 69. India Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 70. Australia Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 71. Germany Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 72. France Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 73. UK Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 74. Italy Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 75. Russia Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 76. Egypt Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 77. South Africa Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 78. Israel Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 79. Turkey Lung Biopsy Systems Market Size 2027-2032 ($ millions)
Figure 80. Global Lung Biopsy Systems Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Lung Biopsy Systems Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Lung Biopsy Systems Market Size 2027-2032 ($ millions)
